FEDERAL STREET STRATEGIES, LLC

Lobbying for ABBVIE, INC. · Biopharmaceutical Research & Development Company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 21, 2025

Lobbying activity 2

Health Issues

Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. Monitoring policies as they relate to PBMs Monitor issues related to the FY2025 budget reconciliation process

Medicare/Medicaid

Medicare Part D policies. Monitoring Policies related to the 340b program. Issues related to the implementation of the Inflation Reduction Act Monitor issues related to the FY2025 budget reconciliation process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.